← Evidence map

Observational studyInternational urogynecology journal2021

OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice.

Rizwan Hamid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 32719964